Recombinant Human UL111A Protein，His

UL111A, a protein encoded by the human cytomegalovirus (HCMV), plays a crucial role in the virus's ability to evade the host immune response. Identified as a multifunctional protein, UL111A functions primarily as a glycoprotein that interacts with various immune receptors, leading to the modulation of immune signaling pathways. Research has shown that UL111A can inhibit the activation of natural killer (NK) cells and T cells, thereby promoting viral persistence and latency. Studies indicate that UL111A achieves this by mimicking host proteins and interfering with cytokine signaling, which are critical for immune activation. Given the prevalence of HCMV in the human population and its potential to cause severe disease in immunocompromised individuals, along with its association with various conditions, including congenital infections and organ transplant rejection, understanding UL111A's mechanisms is essential for developing therapeutic interventions. Recent advancements in recombinant protein technology have enabled the production of UL111A for detailed structural and functional analysis, paving the way for novel vaccine strategies and antiviral therapies that target this viral evasion mechanism. The study of UL111A is not only significant for HCMV pathology but also offers broader insights into viral-host interactions, making it a key target in virology research.